Jubilant Pharmova Limited
Jubilant Pharmova Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: JUBLPHARMA and BSE: 530019 (ISIN INE700A01033).
It has a market capitalisation of ₹14,786 crore, a last close of ₹935.80 on 2026-10-19, a one-year return of -13.3%.
Valuation: a price-to-earnings ratio of 41.99x, a price-to-book ratio of 2.08x, a dividend yield of 0.5%.
Profitability: return on equity of 6.0%, return on capital employed of 7.0%, an operating margin of 14.2%.
Growth: sales growth of 9.6% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.45x, promoter holding of 47.7%.
| Metric | Value |
|---|---|
| Market capitalisation | 14,786 |
| Last close | ₹935.80 |
| P/E (TTM) | 41.99x |
| P/B | 2.08x |
| Dividend yield | 0.5% |
| ROE (FY) | 6.0% |
| ROCE (FY) | 7.0% |
| Operating margin (TTM) | 14.2% |
| Sales growth, 3-year CAGR | 9.6% |
| Debt / equity | 0.45x |
| Promoter holding | 47.7% |
| 1-year return | -13.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means